erythromycin thiocyanate

China began to produce red thiocyanate from the 80s to 90s of the 20th century, but the output was very low and less than 100 tons, and by 2007, erythromycin thiocyanate became the largest export variety of macrolide antibiotics in China, with a production capacity of more than 10,000 tons. The antibacterial spectrum of erythromycin thiocyanate is similar to that of benzylpenicillin, and has a strong effect on Staphylococcus aureus, streptococcus, pneumococcus in Gram-positive bacteria, and also has a certain effect on Pasteurella and Brucella in Gram-negative bacteria: In addition, this product is also effective against mycoplasma, rickettsia, leptospira, actinomycetes, Nocardia, but has no effect on intestinal negative bacilli such as Escherichia coli and Salmonella. It is mainly used for serious infections caused by drug-resistant Staphylococcus aureus and hemolytic streptococcus, such as pneumonia, sepsis, endometritis, mastitis, etc.: it also has a good effect on poultry chronic respiratory disease and pig pneumonia caused by mycoplasma, and is also used for the treatment of nocardiosis in dogs and cats: it can also prevent and control white-headed white-mouth disease of fish fry and fish species such as green, grass, silver carp and bighead carp, bacterial gill rot of grass carp and herring, leukermopathy of silver carp and bighead carp and streptococcal disease of tilapia.